in content lists or on the content page.Sitra’s portfolio company Nexstim reveals significant results from a new combination of therapies which produced significantly greater gains in patients’ motor function 6 months post-stroke (a press release published on 14.2.2014)
This post has been archived and may include outdated content
Nexstim Announces New Stroke Therapy Produced Significant Gains in Motor Function Post-Stroke
Sitra's portfolio company Nexstim reveals significant results from a new combination of therapies which produced significantly greater gains in patients’ motor function 6 months post-stroke
